L

Lawrence J Green, MD LLC | Rockville, MD

Research site

(Unclaimed)

Location

9601 Blackwell Road Suite 260, Rockville, Maryland, United States of America

Site insights

Top conditions

Top treatments

TAK-279

VP-315

Glycopyrronium

Tapinarof

Ritlecitinib

Zasocitinib

Deucravacitinib

ABP 501

Humira®

Sofpironium Bromide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 9 total trials

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents with Nonsegmental Vitiligo (Active and Stable) Tranquillo

Active, not recruiting

Stable Nonsegmental Vitiligo

Active Nonsegmental Vitiligo

Drug: Ritlecitinib

Drug: Placebo

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

The main aim of this study is to assess whether zasocitinib works better than deucravacitinib in treating participants with moderate-to-severe plaque...

Active, not recruiting

Plaque Psoriasis

Drug: Zasocitinib

Drug: Placebo to match zasocitinib

Status recently updated

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...

Enrolling

Active, not recruiting

Plaque Psoriasis

Drug: TAK-279

Status recently updated

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis (Adoring)

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 2...

Not yet enrolling

Enrolling

Atopic Dermatitis

Drug: Vehicle Cream

Drug: Tapinarof cream, 1%